Moderna stock soared as much as 9% on Monday after it said its COVID-19 vaccine booster increases protection against the Omicron variant.
A third dose, which is half the dose level used for each of the first two vaccine shots, resulted in a 37-fold increase in antibody protection against the fast-spreading Omicron variant.
“The dramatic increase in COVID-19 cases from the Omicron variant is concerning to all. However, these data showing that the currently authorized Moderna COVID-19 booster can boost neutralizing antibody levels 37-fold higher than pre-boost levels are reassuring,” said Stéphane Bancel, Chief Executive Officer of Moderna.
